These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18242313)

  • 1. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):1-18. PubMed ID: 20113893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
    Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
    Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pediatric acute lymphoblastic leukemia.
    Tucci F; Aricò M
    Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-risk acute lymphoblastic leukemia].
    Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
    [No Abstract]   [Full Text] [Related]  

  • 12. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.
    Rice SC; Vacek P; Homans AH; Messier T; Rivers J; Kendall H; Finette BA
    Cancer Res; 2004 Jul; 64(13):4464-71. PubMed ID: 15231655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood acute lymphoblastic leukemia.
    Stanulla M; Schrappe M
    Semin Hematol; 2009 Jan; 46(1):52-63. PubMed ID: 19100368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
    Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
    Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
    Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
    Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
    Sońta-Jakimczyk D; Olejnik I; Armata J; Bogusławska-Jaworska J; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Chybicka A; Derwich K; Drabko K; Hicke-Roberts A; Kubiczek K; Steczowicz M
    Wiad Lek; 1998; 51 Suppl 4():52-8. PubMed ID: 10731944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of childhood acute lymphoblastic leukemia.
    Brenner TL; Pui CH; Evan WE
    Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.